118 related articles for article (PubMed ID: 22126917)
1. Usefulness of olanzapine as an adjunct to opioid treatment and for the treatment of neuropathic pain.
Torigoe K; Nakahara K; Rahmadi M; Yoshizawa K; Horiuchi H; Hirayama S; Imai S; Kuzumaki N; Itoh T; Yamashita A; Shakunaga K; Yamasaki M; Nagase H; Matoba M; Suzuki T; Narita M
Anesthesiology; 2012 Jan; 116(1):159-69. PubMed ID: 22126917
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of the dopamine system-stabilizer aripiprazole for reducing morphine-induced emesis.
Shiokawa M; Narita M; Nakamura A; Kurokawa K; Inoue T; Suzuki T
Eur J Pharmacol; 2007 Sep; 570(1-3):108-10. PubMed ID: 17678644
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine suppresses the rewarding and discriminative stimulus effects induced by morphine.
Torigoe K; Mori T; Shibasaki M; Yoshizawa K; Narita M; Suzuki T
Synapse; 2012 Feb; 66(2):174-9. PubMed ID: 22033980
[TBL] [Abstract][Full Text] [Related]
4. Effects of mirtazapine on sleep disturbance under neuropathic pain-like state.
Enomoto T; Yamashita A; Torigoe K; Horiuchi H; Hirayama S; Nakahara K; Yanase M; Sakai H; Ikegami D; Nagase H; Suzuki T; Iseki M; Inada E; Narita M
Synapse; 2012 Jun; 66(6):483-8. PubMed ID: 22213404
[TBL] [Abstract][Full Text] [Related]
5. Effects of gabapentin on brain hyperactivity related to pain and sleep disturbance under a neuropathic pain-like state using fMRI and brain wave analysis.
Takemura Y; Yamashita A; Horiuchi H; Furuya M; Yanase M; Niikura K; Imai S; Hatakeyama N; Kinoshita H; Tsukiyama Y; Senba E; Matoba M; Kuzumaki N; Yamazaki M; Suzuki T; Narita M
Synapse; 2011 Jul; 65(7):668-76. PubMed ID: 21162109
[TBL] [Abstract][Full Text] [Related]
6. Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics.
Ninan I; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):603-8. PubMed ID: 10669905
[TBL] [Abstract][Full Text] [Related]
7. Suppression of dopamine-related side effects of morphine by aripiprazole, a dopamine system stabilizer.
Narita M; Takei D; Shiokawa M; Tsurukawa Y; Matsushima Y; Nakamura A; Takagi S; Asato M; Ikegami D; Narita M; Amano T; Niikura K; Hashimoto K; Kuzumaki N; Suzuki T
Eur J Pharmacol; 2008 Dec; 600(1-3):105-9. PubMed ID: 18955042
[TBL] [Abstract][Full Text] [Related]
8. [Basic studies on cancer pain control].
Yajima Y; Narita M; Ozaki M; Niikura K; Suzuki T
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1377-83. PubMed ID: 16227733
[TBL] [Abstract][Full Text] [Related]
9. Gelsemine alleviates both neuropathic pain and sleep disturbance in partial sciatic nerve ligation mice.
Wu YE; Li YD; Luo YJ; Wang TX; Wang HJ; Chen SN; Qu WM; Huang ZL
Acta Pharmacol Sin; 2015 Nov; 36(11):1308-17. PubMed ID: 26388157
[TBL] [Abstract][Full Text] [Related]
10. A single dose of liposome-encapsulated oxymorphone or morphine provides long-term analgesia in an animal model of neuropathic pain.
Smith LJ; Krugner-Higby L; Clark M; Wendland A; Heath TD
Comp Med; 2003 Jun; 53(3):280-7. PubMed ID: 12868573
[TBL] [Abstract][Full Text] [Related]
11. Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic pain.
Christoph T; De Vry J; Tzschentke TM
Neurosci Lett; 2010 Feb; 470(2):91-4. PubMed ID: 20026182
[TBL] [Abstract][Full Text] [Related]
12. Behavioral pharmacology of olanzapine: a novel antipsychotic drug.
Moore NA; Leander JD; Benvenga MJ; Gleason SD; Shannon H
J Clin Psychiatry; 1997; 58 Suppl 10():37-44. PubMed ID: 9265915
[TBL] [Abstract][Full Text] [Related]
13. Implication of spinal protein kinase C in the suppression of morphine-induced rewarding effect under a neuropathic pain-like state in mice.
Narita M; Oe K; Kato H; Shibasaki M; Narita M; Yajima Y; Yamazaki M; Suzuki T
Neuroscience; 2004; 125(3):545-51. PubMed ID: 15099668
[TBL] [Abstract][Full Text] [Related]
14. Olanzapine and clozapine differently affect sleep in patients with schizophrenia: results from a double-blind, polysomnographic study and review of the literature.
Kluge M; Schacht A; Himmerich H; Rummel-Kluge C; Wehmeier PM; Dalal M; Hinze-Selch D; Kraus T; Dittmann RW; Pollmächer T; Schuld A
Schizophr Res; 2014 Jan; 152(1):255-60. PubMed ID: 24315135
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the in-vivo muscarinic cholinergic receptor availability in patients treated with clozapine and olanzapine.
Raedler TJ
Int J Neuropsychopharmacol; 2007 Apr; 10(2):275-80. PubMed ID: 16945161
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the potential of antipsychotic agents to induce catalepsy in rats: assessment of a new, commercially available, semi-automated instrument.
Bricker B; Sampson D; Ablordeppey SY
Pharmacol Biochem Behav; 2014 May; 120():109-16. PubMed ID: 24565832
[TBL] [Abstract][Full Text] [Related]
17. Olanzapine-induced hyperglycemia: possible involvement of histaminergic, dopaminergic and adrenergic functions in the central nervous system.
Ikegami M; Ikeda H; Ohashi T; Kai M; Osada M; Kamei A; Kamei J
Neuroendocrinology; 2013; 98(3):224-32. PubMed ID: 24135197
[TBL] [Abstract][Full Text] [Related]
18. Effect of a selective GABA(B) receptor agonist baclofen on the mu-opioid receptor agonist-induced antinociceptive, emetic and rewarding effects.
Suzuki T; Nurrochmad A; Ozaki M; Khotib J; Nakamura A; Imai S; Shibasaki M; Yajima Y; Narita M
Neuropharmacology; 2005 Dec; 49(8):1121-31. PubMed ID: 16095635
[TBL] [Abstract][Full Text] [Related]
19. Olanzapine for the prevention and treatment of chronic nausea and chemotherapy-induced nausea and vomiting.
Navari RM
Eur J Pharmacol; 2014 Jan; 722():180-6. PubMed ID: 24157985
[TBL] [Abstract][Full Text] [Related]
20. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
